The organic chemistry of drug design and drug action. Third edition /
Material type:
TextPublisher number: Global Information Systems Technology Pvt Ltd | 877, Udhyog Vihar, Phase-V, GurgaonPublication details: Amsterdam ; Academic Press, an imprint of Elsevier, ©2014Description: xviii, 517 pages : illustrations ; 24 cmISBN: - 9780123820303
- 615.1 SIL
| Item type | Current library | Collection | Call number | Materials specified | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Electronic Resources (E-Books)
|
SNU LIBRARY | Reference | 615.1 SIL (Browse shelf(Opens below)) | Document, Internet resource | Not For Loan | ER40 |
Chapter 1 - Introduction, In The Organic Chemistry of Drug Design and Drug Action
http://www.sciencedirect.com/science/article/pii/B9780123820303000015
Chapter 2 - Lead Discovery and Lead Modification,
http://www.sciencedirect.com/science/article/pii/B9780123820303000027
Chapter 3 - Receptors, In The Organic Chemistry of Drug Design and Drug Action
http://www.sciencedirect.com/science/article/pii/B9780123820303000039
Chapter 4 - Enzymes, In The Organic Chemistry of Drug Design and Drug Action
http://www.sciencedirect.com/science/article/pii/B9780123820303000040
Chapter 5 - Enzyme Inhibition and Inactivation,
http://www.sciencedirect.com/science/article/pii/B9780123820303000052
Chapter 6 - DNA-Interactive Agents,
http://www.sciencedirect.com/science/article/pii/B9780123820303000064
Chapter 7 - Drug Resistance and Drug Synergism,
http://www.sciencedirect.com/science/article/pii/B9780123820303000076
Chapter 8 - Drug Metabolism,
http://www.sciencedirect.com/science/article/pii/B9780123820303000088
Chapter 9 - Prodrugs and Drug Delivery Systems,
http://www.sciencedirect.com/science/article/pii/B978012382030300009X
Abstract : Provides a basis and overall context for concepts introduced and discussed in more detail in subsequent chapters in this book. An historical context is given to the topic of drug discovery, followed by a high level overview of modern approaches to rational drug design. The approaches and steps typically encountered in modern rational drug design, including target identification, lead discovery, and lead modification, are introduced, and an overview of the subsequent steps required for drug development prior to regulatory approval, such as pharmacokinetics, preclinical studies, clinical trials, and intellectual property issues, are summarized.
There are no comments on this title.
